• DOI:10.1007/s00404-016-4027-8
Corpus ID: 25627227

Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy

@article{Kyriakidis2016EstrogenRB,
  title={Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy},
  author={Ioannis Kyriakidis and P. Papaioannidou},
  journal={Archives of Gynecology and Obstetrics},
  year={2016},
  volume={293},
  pages={1161-1168}
}

Ioannis Kyriakidis, P. Papaioannidou

Published 2016

Medicine

Archives of Gynecology and Obstetrics

AbstractIntroduction Ovarian cancer remains the leading cause of mortality due to gynecological tumors. Estrogen receptors (ERs) seem to participate in tumor progression even in the absence of estrogens. Twenty years after the cloning of the second estrogen receptor, a wide spectrum of studies have shown its implication in both physiologic and pathologic pathways. ERβ, being the predominant type of ER in normal ovary tissue, has not only been linked with pathogenesis of ovarian cancer, but also… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed